Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2023-10-26 AGM Information
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
2023 Annual General Meeting Chair and CEO address 4 pages 697.4KB
AGM Information Classification · 95% confidence The document is an ASX announcement dated 27 October 2023, titled 'Medical Developments International Limited 2023 Annual General Meeting Chair & CEO Address.' It contains speeches from the Chair and CEO reflecting on the company's performance over the last financial year, strategic updates, financial highlights such as revenue growth, segment performance, and operational priorities. The content is typical of presentations or materials shared during an Annual General Meeting (AGM), focusing on company performance, strategy, and governance updates. There is no indication that this is a full annual report (10-K) or a regulatory filing. The length (over 10,000 characters) and detailed content support it being AGM materials rather than a brief announcement or report publication notice. Therefore, the document fits best under AGM Information (AGM-R).
2023-10-26 English
Results of Annual General Meeting 2 pages 613.2KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Results of 2023 Annual General Meeting' and references compliance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001, which govern disclosure of AGM voting results. The content consists of detailed voting results for resolutions put to the AGM, including proxy votes and final outcomes. The document is short (3052 characters) and focuses solely on reporting the official voting results of the AGM, not the full AGM materials or presentations. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-10-26 English
Corporate Governance Statement 9 pages 557.7KB
Governance Information Classification · 95% confidence The document is titled 'Corporate Governance Statement' for the financial year 2023 and contains detailed sections on governance highlights, governance model, roles and responsibilities, board of directors, board skills, independence, composition, and board committees. It discusses the company's governance framework, board structure, director independence, and related governance practices. There is no indication that this is an annual report, earnings release, or any other financial report. Instead, it is a detailed governance report focusing on the company's internal rules, board structure, and governance practices. This matches the description of Governance Information (CGR). The document length is substantial (15,000 characters), and it is not a brief announcement or certification, so it is not RPA or RNS. Therefore, the appropriate classification is CGR with high confidence.
2023-09-24 English
Appendix 4G 14 pages 397.6KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a detailed key to corporate governance disclosures, indicating compliance with governance recommendations and where disclosures can be found. The document explicitly states it is not a substitute for the corporate governance statement but a verification tool lodged alongside the annual report. It does not contain financial statements or management discussion but focuses on governance disclosures and compliance with ASX rules. This matches the description of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and content confirm it is a full governance disclosure document, not merely an announcement or certification. Therefore, the correct classification is CGR with high confidence.
2023-09-24 English
Annual Report to Shareholders 46 pages 8.7MB
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT Financial Year ended 30 June 2023' and contains detailed sections typical of an annual report, including a message from the Company Chair, CEO update, company overview, financial highlights, review of operations and financial performance, group results, and financial statements. It includes comprehensive financial data, operational review, strategic outlook, and governance information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is merely an announcement of the report or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2023-09-24 English
Notice of Annual General Meeting and Proxy Form 29 pages 325.4KB
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF 2023 ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUM' for Medical Developments International Limited. It includes details about the date, time, and place of the AGM, instructions for shareholders on voting, proxy appointments, and the resolutions to be considered at the meeting. The document contains no actual financial statements or detailed financial data but references the Annual Report and Remuneration Report to be adopted at the meeting. This is a notice and explanatory memorandum for the AGM, not the AGM materials or the Annual Report itself. Therefore, it fits the category of AGM Information (AGM-R).
2023-09-24 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.